EuclidSR Partners
North America, New York, United States, New York
Description
Successful venture investing combines two essential components: finding opportunities with significant growth potential and helping to
Investor Profile
EuclidSR Partners has backed more than 19 startups, with 0 new investments in the last 12 months alone. The firm has led 4 rounds, about 21% of its total and boasts 9 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series Unknown, Series B rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
Stage Focus
- Series C (26%)
- Series Unknown (16%)
- Series B (16%)
- Series E (16%)
- Series D (11%)
- Private Equity (5%)
- Post Ipo Equity (5%)
- Series A (5%)
Country Focus
- United States (95%)
- United Kingdom (5%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Life Science
- Genetics
- Emergency Medicine
- Business Intelligence
- Information Technology
- Medical
- Biopharma
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.